Dr. Lorri Anne Greene, PHD PSYCHOLOGIST Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2058a Oxford Ave, Cardiff By The Sea, CA 92007 Phone: 760-519-5215 Fax: 760-436-6798 |
Ann White, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2187 Newcastle Ave Ste 103, Cardiff By The Sea, CA 92007 Phone: 310-508-7323 |
Angela Dawn Eastvold, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 120 Birmingham Dr Ste 110a, Cardiff By The Sea, CA 92007 Phone: 760-420-2640 |
Evan Eropkin Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 2340 Carol View Dr Apt E114, Cardiff By The Sea, CA 92007 Phone: 559-289-2732 |
News Archive
NanoPacific Holdings, Inc. (NPH) announces the acquisition of an exclusive license from University of California at Los Angeles (UCLA) for a suite of supramolecular nanoparticle technologies. Under the terms of the agreement between NPH and UCLA, NPH will have an exclusive worldwide license of a system composed of a ternary mixture of modular components that self-assemble into supramolecular nanoparticles.
The long-awaited results from the first large international trial to try to prevent type 1 diabetes shows that modified baby formula in which cow's milk proteins have been split does not prevent type 1 diabetes in children with genetic risk factors for the condition, according to researchers at Children's Hospital of Pittsburgh of UPMC, the coordinating center for the U.S. arm of the study.
H1N1 flu hospitalization rates for African-Americans, Hispanics, and American Indian/Alaska Natives were nearly two to one higher than rates for Whites during the 2009-2010 flu season, according to a new report, Fighting Flu Fatigue, from the Trust for America's Health (TFAH). At the same time, both H1N1 and seasonal flu vaccination rates were lower for African Americans and Hispanics than for Whites.
As the scientific community scrambles to find a drug that can effectively treat tens of thousands of patients sickened by a new respiratory virus, they are trying some surprising remedies: medicines targeting known killers like HIV, Ebola and malaria.
› Verified 8 days ago